All Stories

Galderma, seeking to build $2B product, starts DTC campaign for eczema drug across TV, digital

Galderma has kicked off an ad campaign to show how its Nemluvio can empower people to rule over itchy eczema. Aiming to grow the biologic into a $2 billion product, the company is running ads across national TV and digital media to spread the word about its effects on a particularly bothersome symptom.

Apr 22, 2025 - 15:58
 0
Galderma, seeking to build $2B product, starts DTC campaign for eczema drug across TV, digital
Galderma has kicked off an ad campaign to show how its Nemluvio can empower people to rule over itchy eczema. Aiming to grow the biologic into a $2 billion product, the company is running ads across national TV and digital media to spread the word about its effects on a particularly bothersome symptom.
Read More

Tags:

Previous Article

ID. Aura, ID. Era and ID. Evo: Volkswagen unveils three concept vehicles in Shan...

Next Article

Harvard sues Trump admin over research freeze as its president warns of 'severe ...

Related Posts

Biogen plots 2028 headquarters shift to new 'innovation hub' in Cambridge

Biogen plots 2028 headquarters shift to new 'innovation...

Mar 24, 2025  0

Drugmakers fear Trump tariffs will drive up manufacturing costs, hurt medicine access: BIO survey

Drugmakers fear Trump tariffs will drive up manufacturi...

Mar 26, 2025  0

The Patient as Your Guide: Thriving in New Commercial Models

The Patient as Your Guide: Thriving in New Commercial M...

Feb 10, 2025  0